Budget lays foundation for pharmacare, avoids taxes on pot-based drugs
OTTAWA — The federal Liberals will ask a group of advisers, led by Ontario’s former health minister, to explore options for a national program to cover the cost of prescription drugs and report back in 2019 — ensuring pharmacare becomes a key election campaign issue.
The measure forms a part of a trinity of major drug initiatives in Tuesday’s federal budget, the other two being a $231-million package of steps that aims to confront Canada’s escalating opioid crisis, including $150 million in emergency funding, and tax changes for cannabis-based pharmaceuticals.
Former Ontario health minister Eric Hoskins will head up an advisory council to come up with options on how to create a national pharmacare program — a program that the parliamentary budget watchdog has warned could cost $19 billion a year.
The work will include consulting with provinces, territories and Indigenous groups about what drugs should be included, and the costs involved for “whatever model that we choose,” Health Minister Ginette Petitpas Taylor said after the budget speech with Hoskins at her side.